Syncom Formulations (India) consolidated net profit rises 57.78% in the June 2026 quarter

Sales rise 7.38% to Rs 125.53 crore

Net profit of Syncom Formulations (India) rose 57.78% to Rs 24.85 crore in the quarter ended June 2026 as against Rs 15.75 crore during the previous quarter ended June 2025. Sales rose 7.38% to Rs 125.53 crore in the quarter ended June 2026 as against Rs 116.90 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	125.53	116.90	7
OPM %	20.88	13.52	-
PBDT	33.79	21.59	57
PBT	32.25	20.25	59
NP	24.85	15.75	58

Powered by Capital Market - Live News